BioNTech SE
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,190,000 | $1,228,180 | $129,350 | $188,704 |
Gross Profit | 946,500 | 1,051,669 | 69,248 | 129,256 |
EBITDA | 464,400 | 211,100 | -752,386 | -290,499 |
EBIT | 299,000 | 166,700 | -802,538 | -329,025 |
Net Income | 259,500 | 195,455 | -811,885 | -316,954 |
Net Change In Cash | 1,190,000 | 1,228,180 | 129,350 | 188,704 |
Free Cash Flow | -554,400 | -699,410 | 1,500,662 | -456,873 |
Cash | 9,761,900 | 9,624,600 | 10,382,803 | 8,984,919 |
Basic Shares | 240,277 | 244,567 | 237,725 | 240,534 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,751,100 | $3,819,000 | $17,310,600 | $18,976,700 |
Gross Profit | 2,209,800 | 3,219,200 | 12,778,600 | 15,116,000 |
EBITDA | -367,100 | 1,087,600 | 12,857,778 | 15,730,420 |
EBIT | -665,100 | 904,200 | 12,736,699 | 15,652,220 |
Net Income | -665,300 | 930,300 | 9,434,400 | 10,292,500 |
Net Change In Cash | 2,751,100 | 3,819,000 | 17,310,600 | 18,976,700 |
Free Cash Flow | -244,600 | 4,665,900 | 13,214,100 | 735,700 |
Cash | 9,761,900 | 11,663,700 | 13,875,100 | 1,692,700 |
Basic Shares | 240,400 | 242,700 | 249,800 | 259,700 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $1.08 |
2024-09-30 | $0.88 |
2024-06-30 | -$3.36 |
2024-03-31 | -$1.41 |
